Eva E. Schaake

Tumor Response and Toxicity of Neoadjuvant Erlotinib in Patients With Early-Stage Non–Small-Cell Lung Cancer

Eva E. Schaake, Ingrid Kappers, Henk Codrington et al. · Journal of Clinical Oncology · 2012 · 93 citations · Full text

Medicine, Nuclear Medicine, Oncology +15

Differential Motion Between Mediastinal Lymph Nodes and Primary Tumor in Radically Irradiated Lung Cancer Patients

Eva E. Schaake, Maddalena Rossi, Wieneke A. Buikhuisen et al. · International Journal of Radiation Oncology*Biology*Physics · 2014 · 39 citations

Medicine, Oncology, Radiation Oncology +14

18F-Fluorodeoxyglucose Positron Emission Tomography versus Computed Tomography in Predicting Histopathological Response to Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor Treatment in Resectable Non-Small Cell Lung Cancer

Matthijs H. van Gool, Tjeerd S. Aukema, Eva E. Schaake et al. · Annals of Surgical Oncology · 2014 · 30 citations

Medicine, Oncology, Radiology +14

Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Is Associated with Improved Oncological Outcome in Men Treated with Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer

Dennie Meijer, Wietse S.C. Eppinga, Roos M. Mohede et al. · European Urology Oncology · 2022 · 30 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Deep learning for segmentation of the cervical cancer gross tumor volume on magnetic resonance imaging for brachytherapy

Roque Rodríguez Outeiral, Patrick González, Eva E. Schaake et al. · Radiation Oncology · 2023 · 26 citations · Full text

Medicine, Oncology, Radiation Oncology +17